18 min listen
Bad with names
FromThe BMJ Podcast
ratings:
Length:
11 minutes
Released:
Apr 22, 2016
Format:
Podcast episode
Description
It's bad practice to prescribe a brand name drug when a cheaper, viable and approved generic is available. But, particularly in the US, this happens too much, at major cost to the health system.
The team behind Michigan State University's paediatric clinics set out to increase their prescribing of generics, and found that much of the problem was that whilst brand names lodged in staff and patient's minds, generic names were easily forgotten.
Sath Sudhanthar, paediatrician and assistant professor in paediatrics, and Kari Chandler, nurse manager, tell Harriet Vickers how they overcame this and tripled the team's generic medication prescription rate.
Read their full report: http://qir.bmj.com/content/4/1/u209517.w3931.full
The team behind Michigan State University's paediatric clinics set out to increase their prescribing of generics, and found that much of the problem was that whilst brand names lodged in staff and patient's minds, generic names were easily forgotten.
Sath Sudhanthar, paediatrician and assistant professor in paediatrics, and Kari Chandler, nurse manager, tell Harriet Vickers how they overcame this and tripled the team's generic medication prescription rate.
Read their full report: http://qir.bmj.com/content/4/1/u209517.w3931.full
Released:
Apr 22, 2016
Format:
Podcast episode
Titles in the series (100)
NSAIDs update: Recent research shows that some non-steroidal anti-inflammatory drugs increase cardiovascular risk in some patients. Given their widespread use, and breadth of indications for prescription, should clinicians be more circumspect about their practice?I... by The BMJ Podcast